Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Dechra Pharmaceuticals PLC Director's Dealing 2014

Mar 3, 2014

4797_dirs_2014-03-03_c8e74925-546e-42e0-9c0f-485bc161815a.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3924B

Dechra Pharmaceuticals PLC

03 March 2014

3 March 2014

Dechra® Pharmaceuticals PLC

(Dechra or the Company)

Director / PDMR shareholding

Exercise of LTIP options:

Dechra Pharmaceuticals PLC announces that on 28 February 2014, the following Director and PDMR exercised options over ordinary shares of 1p each in the Company. The options were granted to them on 22 December 2010 pursuant to the Dechra Pharmaceuticals PLC Long Term Incentive Plan (the LTIP): 

Name Capacity Options Exercised Shares Sold Sale Price

per share
Total beneficial shareholding following this announcement Percentage of issued share capital
Ian Page Director 78,656 37,080 £6.9129 906,643 1.035
Zoe Goulding PDMR 8,989 4,238 £6.9129 11,933 0.014

The exercise of the LTIP options were subject to the achievement of performance conditions which vested at 100% of the total award.

Both Ian Page and Zoe Goulding have sold sufficient shares (acquired pursuant to the LTIP exercise) in order to fund the resulting tax liability.  

For further information, please contact:

Melanie Hall, Assistant Company Secretary             

Telephone number: 01606 814730

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and related products business.  Its expertise is in the development, manufacturing and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSQKNDNPBKDBNK